Gardasil royalties are about 20% of CSL's profit, and these are mooted to fall about 20%, and hence the negative impact is some 4%. The market has over reacted to the news that the USA licensee of Gardasil had lowered sales forecasts.
The foregoing arithmetic is a rough approximation, and 4% might be too high, but the thrust of what I write here is probably correct.
Pioupiou
gardasil vaccine eradicating hpv infections, page-2
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.93 |
Change
0.030(0.01%) |
Mkt cap ! $148.8B | |||
| Open | High | Low | Value | Volume |
| $307.51 | $308.38 | $306.26 | $142.0M | 461.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1829 | $307.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.95 | 200 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |